Neoadjuvant Chemotherapy in Head and Neck Cancers

Neoadjuvant chemotherapy (NACT); also called Induction chemotherapy is a treatment option in cancer therapy, in which chemotherapy is given prior to the definitive treatment like surgery or radiotherapy. Neoadjuvant chemotherapy in cancer treatment can reduce the tumor volume, improve organ function prior to definitive treatment, permits more effective and less toxic local therapy. Giving NACT […]

Cell phone radiofrequency could enhance head and neck cancers – New study says

Developments in wireless communication technology over the last twenty years resulted in increasingly widespread use of mobile phones and wireless systems for communication purposes. This has led to concerns regarding potential adverse health effects, particularly of the central nervous system, of which the brain is the part most exposed to the radio frequency electromagnetic fields […]

Replacement of trachea with aortic grafts – a novel treatment for tracheal stenosis

Replacement of trachea after extensive resection still remains as a major challenge for the thoracic surgeons even after decades of intensive research. End to end anastomosis is difficult or almost not possible, when more than 5-6 cm of trachea is resected out. Several clinical solutions with skin, esophagus and bowel etc. have been proposed to tackle […]

Role of Balloon dilatation in chronic rhinosinusitis – Clinical consensus statement 2018

Chronic rhinosinusitis (CRS) is a clinical condition characterised by inflammation of the paranasal sinuses that typically lasts beyond twelve weeks. It is caused by infections, allergies, and the presence of sinus polyps or deviated septum. Signs and symptoms include headache, nasal discharge, swelling in the face, dizziness, and breathing difficulties. The condition is so common […]

Adenotonsillectomy lowers high blood pressure in children with OSA

Obstructive sleep apnea (OSA) is a spectrum of disorders ranging from simple snoring to complete obstruction of upper airways during sleep, which affects both children and adults. The most common cause of obstructive sleep apnea in children is chronic adenotonsillar hypertrophy, and so adenotonsillectomy is considered as the first line treatment for OSA in children.

Microtia kids get new ears from lab with their own cells and 3D printing

Microtia is a congenital external ear deformity characterized by hypoplasia (incomplete development) of pinna, ranging from measurably small external ear with minimal structural abnormality, to ear with major structural alteration or to total absence of ear (anotia). The reported prevalence varies from 0.83 to 17.4 per 10,000 births worldwide. A higher prevalence rates are observed in […]

Sudden Sensorineural Hearing Loss is an early predictor of Cerebrovascular Accidents

Sudden sensorineural hearing loss is an acute dysfunction of the inner ear that affects men and women approximately equally, with a peak age-related incidence occurring between 50 and 60 years. The condition is defined as a documented hearing loss of 30dB or more in 3 or more sequential frequencies, occurring within a period of 3 […]

Adenotonsillectomy can improve bedwetting in children with obstructive sleep apnea

Bladder control in children usually occurs by the age of 5 years. Nocturnal enuresis (NE)or bed wetting, is the involuntary urination during sleep, in absence of physical disease in a child older than 5 years. Nocturnal enuresis affects children of all racial groups. The estimated prevalence rate is 8% to 20% for 5 year old children and 1.5% to 10% […]

Thyroidectomy is better than radioactive iodine therapy in preventing complications of hyperthyroidism

Hyperthyroidism is a clinical condition where the thyroid gland is overactive and produces excess thyroid hormone. The most common causes of hyperthyroidism are Graves’ disease (autoimmune process), toxic nodular goiter and toxic adenoma. Hyperthyroidism affects approximately 2% of women and 0.2% of men with an estimated annual life time risk of 2-5%. The reported incidence of hyperthyroidism […]

Recent updates in guidelines for treatment of Seasonal Allergic Rhinitis

The 2017 Joint Task Force on Practice Parameters (JTFPP) comprising representatives from the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American College of Allergy, Asthma, and Immunology (ACAAI), and the Joint Council of Allergy, Asthma, and Immunology has provided an update to their 2008 guidelines for treatment of seasonal allergic rhinitis (SAR) in adolescents and adults. The updated guidelines […]